Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase

Hepatology

Volumn 29, Issue 4, 1999, Pages 1037-1043

  Park, Joongwon ^a   Gores, Gregory J ^a   Patel, Tushar ^a,b  

^a MAYO CLINIC   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; STAT1 PROTEIN; TUMOR NECROSIS FACTOR;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0032951127     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290423     Document Type: Article

References (14)

1. Crawford J. Cellular and molecular biology of the inflamed liver. Curr Opin Gastroenterol 1997;13:175-185.
2. Callea F, Sergi C, Fabbrelti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol Suppl 1993;3:131-133.
3. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306-315.
4. Alpini G, Phillips J, LaRusso N. The biology of the biliary epithelia. In: Arias I, Boyer J, Fausto N, Jakoby W, Schacter D, Shafritz D, eds. The Liver: Biology and Pathobiology. 3rd ed. New York: Raven 1994:623-653.
5. Roberts SK, Ludwig J, LaRusso NF. The pathobiology of biliary epithelia. Gastroenterology 1997;112:269-279.
6. Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers RE, Caligiuri A, LeSage G. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol 1997;273:(Gastrointest Liver Physiol, 36)G518-G529.
7. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary-cirrhosis and primary sclerosing cholangitis. J Hepatol 1998;29:409-416.
8. Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-278.
9. Kanazawa A, Kinoshita H, Hirohashi K, Kubo S, Tsukamoto T, Hamba H, Shuto T. Concentrations of bile and serum endotoxin and serum cytokines after biliary drainage for acute cholangitis. Osaka City Med J 1997;43:15-27.
10. Rosen HR, Winkle PJ, Kendall BJ, Diehl BL. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopie retrograde cholangiopancreatography. Dig Dis Sci 1997;42:1290-1294.
11. Sehgal P. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol Biol Med 1990;7:117-130.
12. Matsumoto K, Fijii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. HEPATOLOGY 1994;20:376-382.
13. Taga T, Kishioto T. gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.
14. Simpson R, Hammacher A, Smith D, Matthews J. Ward L. Interleukin-6: structure-function relationships. Protein Sci 1997;6:929-955.